POISE-3 Backs Wider Use of TXA in Noncardiac Surgery

The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role for TXA.
Medscape Medical News

source https://www.medscape.com/viewarticle/971483?src=rss